Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

Systemic sclerosis (SSc): comparison of efficacy of oral cyclophosphamide (CYC) and azathioprine (AZA) on skin score and pulmonary involvement-a retrospective study.

pulmonary fibrosis immunosuppressants

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 20 June 2014 - 06:07 AM

Systemic sclerosis (SSc): comparison of efficacy of oral cyclophosphamide (CYC) and azathioprine (AZA) on skin score and pulmonary involvement-a retrospective study.

 

The aim of this study was to evaluate efficacy of (AZA) and (CYC) as a therapeutic regimen for interstitial lung disease associated with (SSc) and the results indicated that AZA can be effective in ameliorating or stabilizing lung function in selected SSc patient groups. PubMed, Rheumatol Int. 2014 May 7. (Also see: Pulmonary Fibrosis and Immunosuppressants)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)